Free Trial

Immunovant (IMVT) Short Interest Ratio & Short Volume

Immunovant logo
$16.49 -0.21 (-1.28%)
As of 01:22 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Immunovant Short Interest Data

Immunovant (IMVT) has a short interest of 16.07 million shares, representing 22.77% of the float (the number of shares available for trading by the public). This marks a -2.19% decrease in short interest from the previous month. The short interest ratio (days to cover) is 12.4, indicating that it would take 12.4 days of the average trading volume of 1.46 million shares to cover all short positions.

Current Short Interest
16,070,000 shares
Previous Short Interest
16,430,000 shares
Change Vs. Previous Month
-2.19%
Dollar Volume Sold Short
$244.59 million
Short Interest Ratio
12.4 Days to Cover
Last Record Date
August 15, 2025
Outstanding Shares
174,317,000 shares
Float Size
70,590,000 shares
Short Percent of Float
22.77%
Today's Trading Volume
789,962 shares
Average Trading Volume
1,461,957 shares
Today's Volume Vs. Average
54%
Short Selling Immunovant?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

IMVT Short Interest Over Time

IMVT Days to Cover Over Time

IMVT Percentage of Float Shorted Over Time

Immunovant Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/202516,070,000 shares $244.59 million -2.2%22.8%12.4 $15.22
7/31/202516,430,000 shares $264.19 million -20.1%23.9%13 $16.08
7/15/202520,570,000 shares $359.77 million +0.6%30.0%16.6 $17.49
6/30/202520,440,000 shares $327.04 million +2.6%29.8%14.6 $16.00
6/15/202519,920,000 shares $311.95 million -8.1%29.1%12.6 $15.66
5/31/202521,680,000 shares $322.38 million +1.3%31.6%12.5 $14.87
5/15/202521,400,000 shares $297.89 million +3.3%31.4%12.7 $13.92
4/30/202520,710,000 shares $334.47 million -0.6%30.4%11.7 $16.15
4/15/202520,830,000 shares $322.24 million +5.8%30.5%11.7 $15.47
3/31/202519,690,000 shares $336.50 million +24.6%28.9%11.6 $17.09
3/15/202515,800,000 shares $308.42 million +2.7%22.8%11 $19.52
2/28/202515,390,000 shares $317.03 million +4.1%22.2%13.3 $20.60
2/15/202514,790,000 shares $300.68 million +12.5%21.3%13.2 $20.33
1/31/202513,150,000 shares $285.88 million +2.5%19.2%11.7 $21.74
1/15/202512,830,000 shares $313.05 million +4.7%21.7%13.8 $24.40
12/31/202412,260,000 shares $303.68 million -2.9%19.7%14.6 $24.77
12/15/202412,630,000 shares $331.92 million -0.3%20.3%14.9 $26.28
11/30/202412,670,000 shares $357.29 million -2.7%20.4%15.2 $28.20
11/15/202413,020,000 shares $346.72 million -0.6%21.0%14.5 $26.63
10/31/202413,100,000 shares $383.31 million +1.3%21.1%15.6 $29.26
10/15/202412,930,000 shares $369.15 million +2.3%20.8%14.3 $28.55
9/30/202412,640,000 shares $360.37 million +1.4%20.4%13.1 $28.51
9/15/202412,460,000 shares $369.69 million +0.6%20.1%11.9 $29.67
8/31/202412,390,000 shares $382.85 million +1.3%20.0%11.9 $30.90
8/15/202412,230,000 shares $377.66 million +9.1%19.8%10.6 $30.88
7/31/202411,210,000 shares $325.87 million +10.1%18.1%9.8 $29.07
7/15/202410,180,000 shares $310.59 million +1.6%16.5%8.9 $30.51
6/30/202410,020,000 shares $264.53 million -1.1%16.0%8.8 $26.40
6/15/202410,130,000 shares $263.38 million +10.0%16.4%8.9 $26.00
5/31/20249,210,000 shares $233.84 million -0.9%15.0%7.8 $25.39
5/15/20249,290,000 shares $287.34 million +3.7%15.3%8.7 $30.93
4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44
4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47
3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31
3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53
2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37
2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80
1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41
1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36
12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13
12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74
11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13
11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24
10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05
10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41
9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39
9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81
8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71
8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52
7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83
7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74
6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97
6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13
5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01
5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41
4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14
4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27
3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51
3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41
2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47
2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13
1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77
1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60
12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75
12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21
11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11
11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29
10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20
10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19
9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58
9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08
8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15
8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16
7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12
7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34
6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90
6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45
5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24
5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04
4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61
4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00
3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51
3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27
2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58
2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72
1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99
1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86
12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52
12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87
11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70
11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18
10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04
10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72
9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69
9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53
8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66
8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88
7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46
7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09
6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57
6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76
5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16
5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61
4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30
4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92
3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00
3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99
2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94
2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49
1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22
1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51
12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33
12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94
11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83
11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67
10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95
10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78
9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19
9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68

IMVT Short Interest - Frequently Asked Questions

What is Immunovant's current short interest?

Short interest is the volume of Immunovant shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 16,070,000 shares of IMVT short. 22.77% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest.

What is a good short interest ratio for Immunovant?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 12.0. Learn More on Immunovant's short interest ratio.

Which institutional investors are shorting Immunovant?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Nomura Holdings Inc., Group One Trading LLC, Boothbay Fund Management LLC, Jane Street Group LLC, Caption Management LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Immunovant?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.77% of Immunovant's floating shares are currently sold short.

Is Immunovant's short interest increasing or decreasing?

Immunovant saw a decline in short interest in the month of August. As of August 15th, there was short interest totaling 16,070,000 shares, a decline of 2.2% from the previous total of 16,430,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Immunovant's float size?

Immunovant currently has issued a total of 174,317,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 70,590,000 shares.

How does Immunovant's short interest compare to its competitors?

22.77% of Immunovant's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Immunovant: Soleno Therapeutics, Inc. (13.73%), Moderna, Inc. (18.29%), BridgeBio Pharma, Inc. (10.72%), Verona Pharma PLC American Depositary Share (2.54%), Elanco Animal Health Incorporated (4.89%), Roivant Sciences Ltd. (8.85%), Grifols, S.A. (0.99%), Revolution Medicines, Inc. (8.12%), Rhythm Pharmaceuticals, Inc. (7.03%), Legend Biotech Corporation Sponsored ADR (4.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

What does it mean to sell short Immunovant stock?

Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunovant?

A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further.

How often is Immunovant's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is August, 15 2025.




This page (NASDAQ:IMVT) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners